Burlington, MANCT03053141Now EnrollingIRB Ready

Cardiac Arrythmias Clinical Trial in Burlington, MA

Access cutting-edge cardiac arrythmias treatment through this clinical trial at a research site in Burlington. Study-provided care at no cost to qualified participants.

Sponsored by Boston Scientific Corporation

Quick Self-Assessment

See if you qualify for this Burlington location

Preparing your pre-screening questions…

Expert Care in Burlington

Access cardiac arrythmias specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related cardiac arrythmias treatment provided free

Apply for This Burlington Location

Check if you qualify for this cardiac arrythmias clinical trial in Burlington, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Burlington

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Burlington site if eligible
  4. 4Begin participation

About This Cardiac Arrythmias Study in Burlington

The objective of the RHAPSODY study is to evaluate the performance of new software features in subjects undergoing standard of care catheter-based endocardial mapping for atrial or ventricular tachyarrhythmias using a commercial Rhythmia Mapping System. Results from this study will be used to guide development and refinement of new software features that may be implemented in future commercial software releases.

Sponsor: Boston Scientific Corporation

Who Can Participate

Inclusion Criteria

Age 18 or above, or above legal age and willing and capable of giving informed consent specific to national law
Scheduled for standard of care catheter-based endocardial mapping for atrial or ventricular tachyarrhythmias using a commercial Rhythmia Mapping System.

Exclusion Criteria

Prothrombotic or bleeding tendency due to coagulopathy or blood dyscrasia
Inability to tolerate heparin therapy (e.g. heparin induced thrombocytopenia, allergy, etc.)
Prosthetic or stenotic valves in the chamber where the intended mapping will occur, or in the path of the catheter access route
Active systemic infection or sepsis
Hemodynamic instability or shock at baseline precluding ablation in the assessment of the investigator.
Presence of intracardiac thrombus, tumor, or other abnormality which precludes catheter introduction
Women who are pregnant or lactating
Cardiac surgery within the past 90 days
Acute myocardial infarction within 3 months
Stable/unstable angina or ongoing myocardial ischemia
Subjects with an active heart failure decompensation
Long QT Syndrome, Brugada Syndrome, or Torsade de Pointes
Congenital heart disease with or without corrective surgery that would complicate a mapping procedure
Subjects having untreatable allergy to contrast media
Vascular pathology or tortuosity precluding standard vascular access techniques
Subjects who are currently enrolled in another investigational study or registry that would directly interfere with the current study, except when the patient is participating in a mandatory governmental registry, or a purely observational registry with no associated treatments. Each instance should be brought to the attention of the sponsor to determine eligibility.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Burlington?

Yes, this clinical trial (NCT03053141) has an active research site in Burlington, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Cardiac Arrythmias Treatment Options in Burlington, MA

If you're searching for cardiac arrythmias treatment options in Burlington, MA, this clinical trial (NCT03053141) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Burlington research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cardiac arrythmias specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all cardiac arrythmias clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Burlington, MA

See all heart attack clinical trials recruiting in Burlington — not just this study.

Browse Heart Attack Trials in Burlington →

Browse More Trials by Condition

Heart Attack TrialsAnkylosing Spondylitis TrialsMyocardial Infarction TrialsAll Conditions →

Ready to Join in Burlington?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Burlington, MA